Skip to main content
Achieve Life Sciences, Inc. logo

Achieve Life Sciences, Inc. Share Price

NASDAQ: ACHVHealthcare

$6.58

+0.14 (2.17%)
BUYSELL

Live Achieve Life Sciences, Inc. Share Price Chart

O 6.44H 6.44L 6.44

Achieve Life Sciences, Inc. Performance Overview

Days Range
▼
$6.25Low
$6.66High

Markets Today

Previous Close$6.38
Open$6.44
Volume643,807
Day's Range$6.25 - $6.66
52W RangeNA
Market Cap$657.28 M

Historical Performance

1M Returns-7.04
3M Returns+1.20
6M Returns+40.50
1Y Returns+46.62
5Y Returns-20.54
10Y ReturnsNA

Achieve Life Sciences, Inc. Fundamentals

Market Cap$657.28 M
Dividend yieldN/A
PE RatioN/A
PEG RatioN/A
Revenue$0.00
ROE TTM-2.58
EPS TTMN/A
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$-54.65 M
Profit MarginN/A
Market Cap$657.28 M
Dividend yieldN/A
PE RatioN/A
PEG RatioN/A
Revenue$0.00
ROE TTM-2.58
EPS TTMN/A
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$-54.65 M
Profit MarginN/A

Achieve Life Sciences, Inc. Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$0$0$0$0$0$0
Gross Profit +$0$0$0$0$0$0
Operating Income -$12.89 M-$12.66 M-$14.69 M-$15.14 M-$10.46 M-$18.49 M
EBITDA -$12.83 M-$12.61 M-$14.64 M-$14.67 M-$10.41 M-$18.43 M
Interest Expense -$185.00 K-$191.00 K-$192.00 K-$251.00 K-$274.00 K-$277.00 K
Depreciation $62.00 K$55.00 K$54.00 K$465.00 K$57.00 K$58.00 K
Income Before Tax -$12.83 M-$12.72 M-$14.44 M-$14.66 M-$10.17 M-$74.77 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$12.83 M-$12.72 M-$14.44 M-$14.66 M-$10.17 M-$74.77 M
Net Profit Margin ------

Achieve Life Sciences, Inc. Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $103.00 K$118.00 K$121.00 K$121.00 K$121.00 K$170.00 K
Reserve & Surplus -$218.40 M-$231.12 M-$245.56 M-$260.22 M-$270.39 M-$345.25 M
Non-Current Liabilities $9.95 M$8.69 M$8.70 M$11.19 M$10.59 M$7.46 M
Current Liabilities $7.13 M$8.57 M$9.73 M$9.08 M$11.83 M$197.66 M
Total Liabilities $17.08 M$17.27 M$18.43 M$20.27 M$22.43 M$205.12 M
Fixed Assets $918.00 K$863.00 K$807.00 K$751.00 K$696.00 K$809.00 K
Current Assets $25.00 M$56.90 M$50.05 M$39.89 M$31.06 M$188.29 M
Total Assets $27.36 M$58.94 M$52.04 M$41.79 M$33.10 M$190.44 M

Achieve Life Sciences, Inc. Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$12.83 M-$12.72 M-$14.44 M-$14.66 M-$10.17 M-$74.77 M
Operating Cash Flow -$11.09 M-$9.07 M-$11.33 M-$17.98 M-$6.93 M-$10.78 M
Investing Cash Flow $11.35 M$6.70 M-$12.65 M$709.00 K$14.28 M-$137.80 M
Financing Cash Flow $0$41.22 M$4.04 M$6.26 M$21.00 K$168.46 M
Change in Cash $263.00 K$38.86 M-$19.94 M-$11.00 M$7.36 M$19.88 M

Achieve Life Sciences, Inc. Return Calculator

The Achieve Life Sciences, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$7,769
Invested Amount$10,000
Est. Returns$-2,231
Invest in USA Stock Today

About Achieve Life Sciences, Inc.

Achieve Life Sciences Inc is a late-stage specialty pharmaceutical company focused on the world-wide development and commercialization of cytisinicline as a treatment for nicotine dependence. Its New Drug Application (NDA) for cytisinicline for smoking cessation in adults is supported by two completed Phase 3 studies and an open-label long-term safety study. It has also completed a Phase 2 study of cytisinicline in nicotine e-cigarette cessation, conducted an end-of-Phase 2 meeting with the FDA, and has received Breakthrough Therapy designation for the vaping cessation indication.

FAQs

Achieve Life Sciences, Inc. (ACHV) share price as of November 7, 2026 is $6.58. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Achieve Life Sciences, Inc. (ACHV) Share by opening an international trading account with Angel One.
Purchasing Achieve Life Sciences, Inc. (ACHV) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Achieve Life Sciences, Inc. (ACHV) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Achieve Life Sciences, Inc. (ACHV) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Achieve Life Sciences, Inc. on November 7, 2026, is $657.28 M.
Achieve Life Sciences, Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Achieve Life Sciences, Inc. (ACHV) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Want to open an NRI account?